Antimicrobial characterization of human β-defensin 3 derivatives

被引:220
作者
Hoover, DM
Wu, ZB
Tucker, K
Lu, WY
Lubkowski, J [1 ]
机构
[1] NCI, Macromol Crystallog Lab, Frederick, MD 21702 USA
[2] NCI, Opportunist Infect Lab, DCTD DTP, SAIC Frederick Inc, Frederick, MD 21702 USA
[3] Univ Baltimore, Inst Biotechnol, Inst Human Virol, Baltimore, MD 21201 USA
关键词
D O I
10.1128/AAC.47.9.2804-2809.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human beta-defensin 3 (hBD3) is a highly basic 45-amino-acid protein that acts both as an antimicrobial agent and as a chemoattractant molecule. Although the nature of its antimicrobial activity is largely electrostatic, the importance of the molecular structure on this activity is poorly understood. Two isoforms of hBD3 were synthesized: the first with native disulfide linkages and the second with normative linkages. In a third synthetic peptide, all cysteine residues were replaced with alpha-aminobutyric acid, creating a completely linear peptide. A series of six small, linear peptides corresponding to regions of hBD3 with net charges ranging from +4 to +8 (at pH 7) and lengths ranging from 9 to 20 amino acids were also synthesized. The linear full-length peptide showed the highest microbicidal activity against Escherichia coli and Staphylococcus aureus, while all three full-length forms showed equal activity against Candida albicans. The linear peptide also showed high activity against Enterococcus faecium and Pseudomonas aeruginosa.. Peptides corresponding to the C terminus showed higher activities when tested against E. coli, with the most active peptides being the most basic. However, only the peptide corresponding to the N terminus of hBD3 showed any activity against S. aureus and C. albicans. Further, N-terminal deletion mutants of native hBD3 showed diminished activities against S. aureus. Thus, the antimicrobial properties of hBD3 derivatives are determined by both charge and structure.
引用
收藏
页码:2804 / 2809
页数:6
相关论文
共 42 条
[1]   HBD-1 - A NOVEL BETA-DEFENSIN FROM HUMAN PLASMA [J].
BENSCH, KW ;
RAIDA, M ;
MAGERT, HJ ;
SCHULZKNAPPE, P ;
FORSSMANN, WG .
FEBS LETTERS, 1995, 368 (02) :331-335
[2]  
Blondelle SE, 2000, BIOPOLYMERS, V55, P74, DOI 10.1002/1097-0282(2000)55:1&lt
[3]  
74::AID-BIP70&gt
[4]  
3.0.CO
[5]  
2-S
[6]   Treponema denticola is resistant to human β-defensins [J].
Brissette, CA ;
Lukehart, SA .
INFECTION AND IMMUNITY, 2002, 70 (07) :3982-3984
[7]  
COCIANCICH S, 1993, J BIOL CHEM, V268, P19239
[8]   DEFENSINS PROMOTE FUSION AND LYSIS OF NEGATIVELY CHARGED MEMBRANES [J].
FUJII, G ;
SELSTED, ME ;
EISENBERG, D .
PROTEIN SCIENCE, 1993, 2 (08) :1301-1312
[9]   DEFENSINS - NATURAL PEPTIDE ANTIBIOTICS OF HUMAN-NEUTROPHILS [J].
GANZ, T ;
SELSTED, ME ;
SZKLAREK, D ;
HARWIG, SSL ;
DAHER, K ;
BAINTON, DF ;
LEHRER, RI .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (04) :1427-1435
[10]   Immunology - Defensins and host defense [J].
Ganz, T .
SCIENCE, 1999, 286 (5439) :420-421